Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending January 18, 2026

Healthcare Private Placement and M&A Transactions Review Week Ending January 18, 2026

by Jonathan Hodson-Walker | Jan 22, 2026 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Inquis Medical: The company raised $75 million of Series C venture funding from undisclosed investors on January 12, 2026, putting the company’s pre-money valuation at $300...
Healthcare Private Placement and M&A Transactions Review Week Ending January 11, 2026

Healthcare Private Placement and M&A Transactions Review Week Ending January 11, 2026

by Jonathan Hodson-Walker | Jan 15, 2026 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Parabilis Medicines: The company raised $305 million of Series F venture funding in a deal led by RA Capital Management, Janus Henderson Investors and Fidelity Management &...
Healthcare Private Placement and M&A Transactions Review Week Ending January 4, 2026

Healthcare Private Placement and M&A Transactions Review Week Ending January 4, 2026

by Jonathan Hodson-Walker | Jan 7, 2026 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Mediar Therapeutics: The company raised $37.8 million of Series B venture funding from undisclosed investors on December 23, 2025, putting the company’s pre-money valuation at...
Healthcare Private Placement and M&A Transactions Review Week Ending December 14, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending December 14, 2025

by Jonathan Hodson-Walker | Dec 16, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Impulse Dynamics: The company raised $158 million of venture funding from Redmile Group, Sands Capital and Perceptive Advisors on December 10, 2025. Alger, Braidwell and other...
Healthcare Private Placement and M&A Transactions Review Week Ending December 7, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending December 7, 2025

by Jonathan Hodson-Walker | Dec 10, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Protego Biopharma: The company raised $130 million of Series B venture funding in a deal led by Novartis Venture Fund and Forbion on December 1, 2025, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending November 30, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending November 30, 2025

by Jonathan Hodson-Walker | Dec 3, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Ablative Solutions: The company raised $76.9 million of Series 2 venture funding from undisclosed investors on November 26, 2025. The company is a developer of catheter-based...
« Older Entries

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending January 18, 2026
  • Consumer Private Placement and M&A Transactions Review Week Ending January 18, 2026
  • Healthcare Private Placement and M&A Transactions Review Week Ending January 18, 2026
  • Technology Private Placement and M&A Transactions Review Week Ending January 11, 2026
  • Consumer Private Placement and M&A Transactions Review Week Ending January 11, 2026

Categories

Archives